ASPHF
Price
$5.83
Change
+$0.40 (+7.38%)
Updated
Jan 22 closing price
Capitalization
3.68B
INTI
Price
$0.05
Change
+$0.01 (+25.00%)
Updated
Jul 2 closing price
Capitalization
8.27M
Interact to see
Advertisement

ASPHF vs INTI

Header iconASPHF vs INTI Comparison
Open Charts ASPHF vs INTIBanner chart's image
ASCENTAGE PHARMA GROUP
Price$5.83
Change+$0.40 (+7.38%)
Volume$400
Capitalization3.68B
Inhibitor Therapeutics
Price$0.05
Change+$0.01 (+25.00%)
Volume$1.5K
Capitalization8.27M
ASPHF vs INTI Comparison Chart in %
Loading...
INTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASPHF vs. INTI commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASPHF is a Hold and INTI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (ASPHF: $5.82 vs. INTI: $0.05)
Brand notoriety: ASPHF and INTI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASPHF: 100% vs. INTI: 6%
Market capitalization -- ASPHF: $3.68B vs. INTI: $8.27M
ASPHF [@Biotechnology] is valued at $3.68B. INTI’s [@Biotechnology] market capitalization is $8.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASPHF’s FA Score shows that 0 FA rating(s) are green whileINTI’s FA Score has 0 green FA rating(s).

  • ASPHF’s FA Score: 0 green, 5 red.
  • INTI’s FA Score: 0 green, 5 red.
According to our system of comparison, ASPHF is a better buy in the long-term than INTI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INTI’s TA Score shows that 3 TA indicator(s) are bullish.

  • INTI’s TA Score: 3 bullish, 4 bearish.

Price Growth

ASPHF (@Biotechnology) experienced а 0.00% price change this week, while INTI (@Biotechnology) price change was +0.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ASPHF($3.69B) has a higher market cap than INTI($8.27M). ASPHF YTD gains are higher at: 116.543 vs. INTI (-20.133).
ASPHFINTIASPHF / INTI
Capitalization3.69B8.27M44,548%
EBITDAN/A-3.56M-
Gain YTD116.543-20.133-579%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A4.32M-
Total DebtN/A84.3K-
FUNDAMENTALS RATINGS
INTI: Fundamental Ratings
INTI
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
98
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
90
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ASPHFINTI
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 4 days ago
65%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
9%
Bullish Trend 4 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
6%
Bullish Trend 4 days ago
68%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 7 days ago
87%
BollingerBands
ODDS (%)
N/A
Bullish Trend 5 days ago
77%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
INTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BATT9.630.12
+1.28%
Amplify Lithium & Battery Tech ETF
ILCV84.990.45
+0.53%
iShares Morningstar Value ETF
BSMR23.540.01
+0.04%
Invesco BulletShares 2027 Muncpl Bd ETF
MAPP23.86N/A
N/A
Harbor Multi-Asset Explorer ETF
CPRO25.17N/A
N/A
Calamos Russell 2000 Str Alt Prt ETF-Oct

ASPHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASPHF has been loosely correlated with NERV. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ASPHF jumps, then NERV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASPHF
1D Price
Change %
ASPHF100%
N/A
NERV - ASPHF
44%
Loosely correlated
-4.62%
GPCR - ASPHF
31%
Poorly correlated
-0.37%
NURPF - ASPHF
30%
Poorly correlated
N/A
PYPD - ASPHF
24%
Poorly correlated
+0.29%
GOSS - ASPHF
24%
Poorly correlated
+2.48%
More

INTI and

Correlation & Price change

A.I.dvisor indicates that over the last year, INTI has been loosely correlated with TENX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if INTI jumps, then TENX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INTI
1D Price
Change %
INTI100%
N/A
TENX - INTI
44%
Loosely correlated
+1.22%
BCDA - INTI
35%
Loosely correlated
+1.73%
ASPHF - INTI
24%
Poorly correlated
N/A
IVEVF - INTI
17%
Poorly correlated
N/A
IDRSF - INTI
6%
Poorly correlated
N/A
More